🇺🇸 FDA
Patent

US 6767541

HER-2/neu overexpression abrogates growth inhibitory pathways

expired A61KA61K2039/505A61K39/39558

Quick answer

US patent 6767541 (HER-2/neu overexpression abrogates growth inhibitory pathways) held by The Regents of the University of California expires Mon Jul 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61K39/39558